PH12019501629A1 - Probiotic compositions and uses therof - Google Patents
Probiotic compositions and uses therofInfo
- Publication number
- PH12019501629A1 PH12019501629A1 PH12019501629A PH12019501629A PH12019501629A1 PH 12019501629 A1 PH12019501629 A1 PH 12019501629A1 PH 12019501629 A PH12019501629 A PH 12019501629A PH 12019501629 A PH12019501629 A PH 12019501629A PH 12019501629 A1 PH12019501629 A1 PH 12019501629A1
- Authority
- PH
- Philippines
- Prior art keywords
- lactobacillus
- probiotic compositions
- uses therof
- dsm
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1700542.2A GB201700542D0 (en) | 2017-01-12 | 2017-01-12 | Probiotic compositions and uses thereof |
| GBGB1709731.2A GB201709731D0 (en) | 2017-06-19 | 2017-06-19 | Probiotic compositions and uses thereof |
| PCT/EP2018/050789 WO2018130667A1 (en) | 2017-01-12 | 2018-01-12 | Probiotic compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019501629A1 true PH12019501629A1 (en) | 2020-06-01 |
Family
ID=61386800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019501629A PH12019501629A1 (en) | 2017-01-12 | 2019-07-12 | Probiotic compositions and uses therof |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11166993B2 (enExample) |
| EP (1) | EP3568144B1 (enExample) |
| JP (1) | JP7089523B2 (enExample) |
| KR (1) | KR102500496B1 (enExample) |
| CN (1) | CN110177561B (enExample) |
| AU (1) | AU2018207946B2 (enExample) |
| CA (1) | CA3049624A1 (enExample) |
| CL (1) | CL2019001938A1 (enExample) |
| MX (1) | MX2019008292A (enExample) |
| MY (1) | MY195253A (enExample) |
| PH (1) | PH12019501629A1 (enExample) |
| RU (1) | RU2763311C2 (enExample) |
| WO (1) | WO2018130667A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112584848A (zh) * | 2018-06-18 | 2021-03-30 | 普罗比公司 | 益生菌组合物及其用途 |
| IT201900014550A1 (it) * | 2019-08-09 | 2021-02-09 | Abiogen Pharma Spa | Uso di colecalciferolo come agente attivo nel trattamento della celiachia |
| CN116869141A (zh) * | 2022-05-05 | 2023-10-13 | 内蒙古一康健康发展有限责任公司 | 一种具有保健功能的益生菌复合物及其制备方法 |
| KR102845919B1 (ko) * | 2023-02-28 | 2025-08-14 | 주식회사 피엘비앤비 | 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물 |
| CN119279210A (zh) * | 2024-12-16 | 2025-01-10 | 山东健源生物科技有限公司 | 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| ZA200802934B (en) * | 2005-10-06 | 2009-09-30 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| KR101300086B1 (ko) * | 2005-10-06 | 2013-08-30 | 프로비 아베 | 자가면역질환의 치료를 위한 락토바실러스의 용도 |
| WO2007108763A1 (en) | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
| US8137952B2 (en) | 2006-03-17 | 2012-03-20 | Probac Ab | Thermostable lactobacillus strains |
| EP3269379A1 (en) | 2008-11-30 | 2018-01-17 | Immusant, Inc. | Compositions and methods for treatment of celiac disease |
| EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
| MX363899B (es) | 2012-06-18 | 2019-04-05 | Heinz Co Brands H J Llc | Trastornos relacionados con gluten. |
| KR102129934B1 (ko) * | 2013-04-03 | 2020-07-03 | 프로비 아베 | 골다공증의 치료 또는 예방에 사용되는 프로바이오틱 스트레인 |
| WO2016083450A2 (en) * | 2014-11-25 | 2016-06-02 | Stichting Top Institute Food And Nutrition | New probiotic and new biomarker |
-
2018
- 2018-01-12 MX MX2019008292A patent/MX2019008292A/es unknown
- 2018-01-12 JP JP2019538207A patent/JP7089523B2/ja active Active
- 2018-01-12 CA CA3049624A patent/CA3049624A1/en active Pending
- 2018-01-12 RU RU2019121145A patent/RU2763311C2/ru active
- 2018-01-12 EP EP18707627.8A patent/EP3568144B1/en active Active
- 2018-01-12 KR KR1020197022803A patent/KR102500496B1/ko active Active
- 2018-01-12 MY MYPI2019003890A patent/MY195253A/en unknown
- 2018-01-12 AU AU2018207946A patent/AU2018207946B2/en active Active
- 2018-01-12 CN CN201880006818.0A patent/CN110177561B/zh active Active
- 2018-01-12 WO PCT/EP2018/050789 patent/WO2018130667A1/en not_active Ceased
- 2018-01-12 US US16/477,259 patent/US11166993B2/en active Active
-
2019
- 2019-07-11 CL CL2019001938A patent/CL2019001938A1/es unknown
- 2019-07-12 PH PH12019501629A patent/PH12019501629A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110177561A (zh) | 2019-08-27 |
| BR112019014418A2 (pt) | 2020-04-14 |
| US20190358275A1 (en) | 2019-11-28 |
| EP3568144A1 (en) | 2019-11-20 |
| WO2018130667A1 (en) | 2018-07-19 |
| JP7089523B2 (ja) | 2022-06-22 |
| AU2018207946A1 (en) | 2019-07-25 |
| US11166993B2 (en) | 2021-11-09 |
| AU2018207946B2 (en) | 2024-07-18 |
| RU2019121145A3 (enExample) | 2021-04-26 |
| RU2019121145A (ru) | 2021-02-12 |
| KR102500496B1 (ko) | 2023-02-16 |
| JP2020513780A (ja) | 2020-05-21 |
| CA3049624A1 (en) | 2018-07-19 |
| CN110177561B (zh) | 2023-09-12 |
| EP3568144B1 (en) | 2024-05-08 |
| RU2763311C2 (ru) | 2021-12-28 |
| EP3568144C0 (en) | 2024-05-08 |
| KR20190104568A (ko) | 2019-09-10 |
| MX2019008292A (es) | 2019-09-16 |
| CL2019001938A1 (es) | 2019-09-27 |
| MY195253A (en) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019008292A (es) | Composiciones probioticas y usos de las mismas. | |
| EP4484581A3 (en) | Akkermansia muciniphila eb-amdk19 strain and use thereof | |
| MX2022000369A (es) | Cepa bacteriana de bifidobacterium bifidum, las composiciones de la misma y usos relacionados. | |
| EP4086334A4 (en) | LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES | |
| NZ712959A (en) | Probiotic strains for use in treatment or prevention of osteoporosis | |
| EA202091389A1 (ru) | Композиция на основе пробиотиков и её применение | |
| MY160508A (en) | Lactobacillus plantarum strains as hypocholesterolemic agents | |
| WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
| MX346458B (es) | Composicion probiotica para la salud bucal. | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
| EP4086335A4 (en) | LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME | |
| UA109876C2 (uk) | Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів | |
| MX2016014991A (es) | Composiciones que contienen acido borico y una mezcla de lactobacilos. | |
| BR112017023636A2 (pt) | suplemento dietético | |
| WO2018135843A3 (ko) | 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물 | |
| MX2024008818A (es) | Un producto de combinacion util para profilaxis y tratamiento de sindrome de intestino irritable. | |
| MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
| MY202532A (en) | Therapeutic uses of lactobacillus plantarum | |
| GEAP201914591A (en) | Histamine-producing bacterial strains and their use in cancer | |
| PT3741218T (pt) | Estirpe de lactobacillus salivarus e seu uso na prevenção e tratamento de diarreia pós-desmame em leitões | |
| MX2020013860A (es) | Composiciones probioticas y sus usos. | |
| TW201613549A (en) | Abraisive oral care composition | |
| WO2019022602A8 (en) | Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery | |
| MX2020007906A (es) | Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. |